BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 35781741)

  • 1. The accuracy of clinical neck staging for p16-positive and negative oropharyngeal cancer and its therapeutic implications.
    Hussain T; Thangavelu K; Kürten C; Galland L; Höing B; Deuss E; Mattheis S; Lang S; Deuschl C; Forsting M; Dörner N
    Eur Arch Otorhinolaryngol; 2022 Nov; 279(11):5339-5345. PubMed ID: 35781741
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Extracapsular extension of neck nodes and absence of human papillomavirus 16-DNA are predictors of impaired survival in p16-positive oropharyngeal squamous cell carcinoma.
    Freitag J; Wald T; Kuhnt T; Gradistanac T; Kolb M; Dietz A; Wiegand S; Wichmann G
    Cancer; 2020 Jan; 126(9):1856-1872. PubMed ID: 32032442
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Implications of updated staging system for p16+ oropharyngeal squamous cell carcinoma: Is valuable prognostic information being omitted?
    Vo K; Ladbury C; Tam A; Maghami E; Kang R; Villaflor V; Agulnik M; Gernon T; Glaser S; Amini A
    Head Neck; 2023 Aug; 45(8):2079-2086. PubMed ID: 37345637
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The prognostic value of extranodal extension in human papillomavirus-associated oropharyngeal squamous cell carcinoma.
    An Y; Park HS; Kelly JR; Stahl JM; Yarbrough WG; Burtness BA; Contessa JN; Decker RH; Koshy M; Husain ZA
    Cancer; 2017 Jul; 123(14):2762-2772. PubMed ID: 28323338
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Extranodal extension is a strong prognosticator in HPV-positive oropharyngeal squamous cell carcinoma.
    Bauer E; Mazul A; Chernock R; Rich J; Jackson RS; Paniello R; Pipkorn P; Oppelt P; Gay H; Daly M; El-Mofty S; Thorstad W; Adkins D; Zevallos J
    Laryngoscope; 2020 Apr; 130(4):939-945. PubMed ID: 31077394
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of AJCC 8th edition staging system and definitive treatment choice on the prognosis of complete responders with p16+ and p16- oropharyngeal squamous cell carcinomas.
    Muller RG; Hamill CS; Vu B; Thuener J; Wasman J; Li S; Fowler N; Rezaee R; Lavertu P; Yao M; Burkitt K; Dorth J; Teknos TN; Pan Q; O'Neill WQ
    Oral Oncol; 2022 May; 128():105861. PubMed ID: 35436712
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The prognostic significance of the biomarker p16 in oropharyngeal squamous cell carcinoma.
    Oguejiofor KK; Hall JS; Mani N; Douglas C; Slevin NJ; Homer J; Hall G; West CM
    Clin Oncol (R Coll Radiol); 2013 Nov; 25(11):630-8. PubMed ID: 23916365
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A systematic investigation of the association between HPV and the clinicopathological parameters and prognosis of oral and oropharyngeal squamous cell carcinomas.
    Wang F; Zhang H; Xue Y; Wen J; Zhou J; Yang X; Wei J
    Cancer Med; 2017 May; 6(5):910-917. PubMed ID: 28378539
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patterns and distribution of regional nodal involvement and recurrence in a surgically treated oropharyngeal squamous cell carcinoma cohort at a tertiary center.
    Abdel-Halim CN; O'Byrne TJ; Graves JP; Akpala CO; Moore EJ; Price DL; Tasche KT; Ma DJ; Neben-Wittich MA; Lester SC; Gamez M; Price KA; Bayne HEF; Rwigema JCM; Patel SH; McGee LA; Janus JR; Nagel TH; Hinni ML; Savvides PS; Van Abel KM; Routman DM
    Oral Oncol; 2023 Nov; 146():106569. PubMed ID: 37734203
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic factors and survival unique to surgically treated p16+ oropharyngeal cancer.
    Haughey BH; Sinha P
    Laryngoscope; 2012 Sep; 122 Suppl 2():S13-33. PubMed ID: 22926949
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Primary tumor volume and prognosis for patients with p16-positive and p16-negative oropharyngeal squamous cell carcinoma treated with radiation therapy.
    Adrian G; Carlsson H; Kjellén E; Sjövall J; Zackrisson B; Nilsson P; Gebre-Medhin M
    Radiat Oncol; 2022 Jun; 17(1):107. PubMed ID: 35701827
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human Papillomavirus-Associated Oropharyngeal Cancer: Patterns of Nodal Disease.
    Plonowska KA; Strohl MP; Wang SJ; Ha PK; George JR; Heaton CM; El-Sayed IH; Mallen-St Clair J; Ryan WR
    Otolaryngol Head Neck Surg; 2019 Mar; 160(3):502-509. PubMed ID: 30274544
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The prognostic effect of radiological extranodal extension in HPV-positive oropharyngeal squamous cell carcinomas: a retrospective cohort analysis.
    Meulemans J; Werpin L; Hermans R; Laenen A; Nuyts S; Clement PM; Delaere P; Van Lierde C; Vander Poorten V
    Eur Arch Otorhinolaryngol; 2024 Mar; 281(3):1541-1558. PubMed ID: 38170212
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic Value of Radiologic Extranodal Extension in Human Papillomavirus-Related Oropharyngeal Squamous Cell Carcinoma.
    Lee B; Choi YJ; Kim SO; Lee YS; Hong JY; Baek JH; Lee JH
    Korean J Radiol; 2019 Aug; 20(8):1266-1274. PubMed ID: 31339014
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Does Bulky Adenopathy in Human Papilloma Virus-Positive Oropharyngeal Squamous Cell Carcinoma Require a Planned Post-Treatment Neck Dissection for Occult Residual Disease?
    Kim RY; Vincent AG; Shokri T; Ducic Y
    J Oral Maxillofac Surg; 2023 Feb; 81(2):248-253. PubMed ID: 36528082
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of Core Biopsy With Extranodal Extension in Surgically Treated Human Papillomavirus-Associated Oropharyngeal Squamous Cell Carcinoma.
    Zhu VL; Rand DR; Arnold KE; Pagedar NA; Bayon R; Buchakjian MR
    JAMA Otolaryngol Head Neck Surg; 2023 Nov; 149(11):955-960. PubMed ID: 37433026
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular predictors of locoregional and distant metastases in oropharyngeal squamous cell carcinoma.
    Barber BR; Biron VL; Klimowicz AC; Puttagunta L; Côté DW; Seikaly H
    J Otolaryngol Head Neck Surg; 2013 Oct; 42(1):53. PubMed ID: 24401183
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Survival of patients with oropharyngeal squamous cell carcinomas (OPSCC) in relation to TNM 8 - Risk of incorrect downstaging of HPV-mediated non-tonsillar, non-base of tongue carcinomas.
    Marklund L; Holzhauser S; de Flon C; Zupancic M; Landin D; Kolev A; Haeggblom L; Munck-Wikland E; Hammarstedt-Nordenvall L; Dalianis T; Näsman A
    Eur J Cancer; 2020 Nov; 139():192-200. PubMed ID: 32951963
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic impact of extranodal extension (ENE) in surgically managed treatment-naive HPV-positive oropharyngeal squamous cell carcinoma with nodal metastasis.
    Xu B; Saliba M; Alzumaili B; Alghamdi M; Lee N; Riaz N; Patel SG; Ganly I; Dogan S; Ghossein RA; Katabi N
    Mod Pathol; 2022 Nov; 35(11):1578-1586. PubMed ID: 35690646
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Occult contralateral nodal disease in oropharyngeal squamous cell carcinoma patients undergoing primary TORS with bilateral neck dissection.
    McMullen CP; Garneau J; Weimar E; Ali S; Farinhas JM; Yu E; Som PM; Sarta C; Goldstein DP; Su S; Xu W; Smith RV; Miles B; de Almeida JR
    Oral Oncol; 2019 Jun; 93():96-100. PubMed ID: 31109703
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.